Related Experiment Videos
Hydrocephalus induced by cyclophosphamide in chick embryos
Neurosurgery
|July 1, 1990
Insights
Cyclophosphamide exposure in developing chick embryos resulted in a 37% incidence of hydrocephalus. This condition was linked to aqueductal abnormalities and choroid plexus hypertrophy in some embryos.
Area of Science:
- Developmental biology
- Teratology
- Neuroscience
Background:
- The developing central nervous system is vulnerable to teratogenic agents.
- Understanding the impact of specific chemical exposures during embryogenesis is crucial for identifying developmental risks.
Purpose of the Study:
- To investigate the teratogenic effects of cyclophosphamide on chick embryo development.
- To assess the incidence of specific central nervous system malformations following embryonic cyclophosphamide exposure.
Main Methods:
- Cyclophosphamide was administered via yolk sac injection to chick embryos on days 0-5 of incubation.
- Embryos were collected on day 21 of incubation for morphological examination.
Main Results:
- A 37% incidence of hydrocephalus was observed in chick embryos exposed to cyclophosphamide.
- Agenesis or stenosis of the aqueduct and choroid plexus hypertrophy were noted in 20% of the affected embryos.
Conclusions:
- Cyclophosphamide is a potent teratogen that can induce hydrocephalus in chick embryos.
- Embryonic exposure to cyclophosphamide can lead to structural abnormalities in the brain, including aqueductal defects and choroid plexus changes.
Abstract:
Cyclophosphamide was injected into the yolk sac of chick embryos for 6 days (Days 0-5). Embryos collected on the 21st day of incubation had a 37% incidence of hydrocephalus. Agenesis or stenosis of the aqueduct, as well as hypertrophy of the choroid plexus, was observed in 20% of the embryos.